PatternsRadar
Sign in

INDSWFTLABInd-Swift Laboratories Limited

NSEASM Stage I
317.05INR-13.15 (-3.98%)Close · 20 Nov 2026
29 Oct 2026Last results
HealthcareSector
Pharmaceuticals & BiotechnologyIndustry
₹2,757 CrMarket cap
33.0P/E (TTM)
49.8%Delivery

Filings & corporate actions

79 results filed
CSV
Next results · Q3 FY27
Expected 31 Jan 2027 – 15 Feb 2027
Estimate: filed 31–46 days after quarter end, last 5 times
2026
  • 29 OctresultsResults · Q2 FY27 · consolidated and standalone-10.2%NSE
  • 15 OctshareholdingShareholding · 30 Sept 2026-3.2%NSE
  • 25 SeptshareholdingShareholding · 17 Sept 2026+0.8%NSE
  • 10 AugresultsResults · Q1 FY27 · consolidated and standalone+20.0%NSE
  • 20 JulshareholdingShareholding · 30 Jun 2026+1.1%NSE
  • 28 MayresultsResults · Q4 FY26 · consolidated and standalone+12.8%NSE
  • 21 AprshareholdingShareholding · 31 Mar 2026+3.6%NSE
  • 5 MarshareholdingShareholding · 24 Feb 2026+8.7%NSE
  • 31 JanresultsResults · Q3 FY26 · consolidated and standalone-0.6%NSE
  • 21 JanshareholdingShareholding · 31 Dec 2025-1.1%NSE

Reaction to results · all yearsrose on day 0 in 33 of 79 CSV

QuarterFiledDay 0+5D+20DRel vol
Q2 FY2729 Oct 2026-10.2%-15.0%—5.7×
Q1 FY2710 Aug 2026+20.0%+46.2%+63.7%20.1×
Q4 FY2628 May 2026+12.8%+17.2%+52.2%13.5×
Q3 FY2631 Jan 2026-0.6%+16.6%+28.1%0.8×
Q2 FY2614 Nov 2025-4.0%-7.7%-5.9%2.8×
Q1 FY2613 Aug 2025-3.9%-7.2%+0.1%0.5×
Q4 FY2512 Aug 2025+0.5%-3.5%+4.4%0.3×
Q3 FY2514 Feb 2025+3.8%-0.8%+1.7%2.5×
Q2 FY2512 Nov 2024-2.0%-8.5%+3.1%0.8×
Q1 FY2513 Aug 2024-4.6%-15.9%-7.3%1.1×
Q4 FY2414 May 2024+2.9%-2.3%+8.5%1.8×
Q3 FY2412 Feb 2024-3.9%+8.0%+3.8%1.4×
Q2 FY248 Nov 2023-0.7%-0.4%-4.0%1.1×
Q1 FY2410 Aug 2023-1.9%-8.0%-5.5%0.6×
Q4 FY2330 May 2023-0.8%-0.1%+19.9%0.9×
Q3 FY2315 Feb 2023+0.8%-2.2%-8.9%1.5×
Q2 FY239 Nov 2022+20.0%+20.2%+21.3%32.6×
Q1 FY2310 Aug 2022+0.5%+5.5%+0.8%0.9×
Q4 FY2229 May 2022-5.1%+2.4%+2.2%2.8×
Q3 FY229 Feb 2022-8.3%-15.9%-21.2%1.7×
Q2 FY222 Nov 2021+10.0%+21.0%+21.9%1.9×
Q1 FY2213 Aug 2021+3.6%-23.1%-8.3%0.2×
Q4 FY2130 Jun 2021-11.3%-4.4%+4.6%1.3×
Q3 FY2113 Feb 2021-5.0%-6.9%+10.8%1.6×
Q2 FY2110 Nov 2020+0.6%+23.2%+23.0%0.6×
Q1 FY2125 Jul 2020-5.0%-0.7%+8.0%3.8×
Q4 FY2021 Jun 2020-1.0%-14.8%-10.1%5.2×
Q3 FY2014 Feb 2020+0.7%-2.8%-15.0%1.3×
Q2 FY2012 Nov 2019-4.5%-6.9%-18.6%1.7×
Q4 FY199 Sept 2019+0.2%+0.9%-12.3%1.2×
Q1 FY2010 Aug 2019+2.1%+5.5%+37.4%3.0×
Q3 FY1919 Feb 2019+6.5%+1.3%-1.0%3.0×
Q2 FY1927 Nov 2018-0.5%-6.8%-16.6%1.1×
Q1 FY1931 Aug 2018+1.6%-1.7%-31.0%0.8×
Q4 FY1829 Jun 2018-2.6%+3.1%-5.8%0.5×
Q3 FY1828 Feb 2018-2.7%-7.3%-13.0%1.2×
Q2 FY1826 Dec 2017+10.0%+15.9%-5.5%3.1×
Q1 FY1822 Sept 2017-2.7%-3.0%-1.2%0.7×
Q4 FY1715 Jun 2017+2.4%0.0%-0.4%0.9×
Q3 FY1715 Feb 2017-0.6%+2.2%+1.5%0.6×
Q2 FY1715 Nov 2016-1.1%-3.0%+3.6%0.3×
Q1 FY1713 Aug 2016-0.7%-4.1%+4.8%0.9×
Q4 FY1626 May 2016-2.3%+1.5%-4.9%0.8×
Q3 FY1615 Feb 2016-6.5%-10.0%+15.6%0.6×
Q2 FY1627 Oct 2015-1.8%-8.4%-6.6%0.5×
Q1 FY1613 Aug 2015-0.1%+1.3%-18.4%0.8×
Q4 FY1521 May 2015-1.0%+2.8%-3.8%1.0×
Q3 FY1510 Feb 2015+5.9%+11.2%+8.8%2.5×
Q2 FY1513 Nov 2014-2.6%-5.8%-16.3%0.5×
Q1 FY1518 Aug 2014-2.2%+2.8%+16.2%0.3×
Q4 FY141 Jul 2014-3.4%-9.8%-15.4%0.5×
Q3 FY1412 Feb 2014+4.2%+0.6%+18.8%0.9×
Q2 FY1422 Nov 2013-1.3%+6.5%+26.0%1.3×
Q1 FY1414 Aug 2013-0.4%-1.3%-0.2%1.3×
Q4 FY1314 Jun 2013-0.4%-2.4%-3.3%0.8×
Q3 FY1319 Feb 2013+0.1%-0.2%-0.6%1.0×
Q2 FY138 Nov 2012-2.9%-8.6%-11.9%0.9×
Q1 FY1323 Aug 2012+12.0%+8.4%+28.8%12.5×
Q4 FY126 Jun 2012-0.1%-7.2%-17.1%2.2×
Q3 FY129 Feb 2012-1.5%-4.3%-18.9%1.3×
Q2 FY1216 Nov 2011-4.3%-21.0%-19.5%0.6×
Q1 FY1220 Aug 2011+2.3%+1.5%+17.1%0.8×
Q4 FY1126 May 2011-0.4%+3.1%-3.2%2.1×
Q3 FY1131 Jan 2011+1.7%+7.4%-3.7%4.5×
Q2 FY1115 Nov 2010+1.0%-11.6%-30.0%0.9×
Q1 FY1129 Jul 2010-1.1%-2.1%+53.3%0.4×
Q4 FY1031 May 2010+5.2%-0.3%+11.4%4.2×
Q3 FY1028 Jan 2010+3.0%-0.4%-4.0%0.8×
Q2 FY1030 Oct 2009-5.2%+4.7%+8.2%0.5×
Q1 FY1030 Jul 2009+1.9%+14.7%+47.5%1.6×
Q4 FY0929 Jun 2009-0.7%-10.3%-1.3%1.1×
Q3 FY0929 Jan 2009+2.3%-1.6%-6.6%0.9×
Q2 FY0925 Oct 2008-3.8%+16.8%-0.4%1.0×
Q1 FY0930 Jul 2008+4.9%+5.3%+2.2%4.7×
Q4 FY0819 Jun 2008-3.7%-13.7%-19.3%2.1×
Q3 FY0829 Jan 2008-3.7%+1.2%+1.5%0.5×
Q2 FY0829 Oct 2007+0.8%-0.1%+10.0%1.3×
Q1 FY0810 Aug 2007+0.9%-11.0%-0.5%0.3×
Q4 FY073 May 2007+0.8%-7.1%-7.9%1.8×
Average+0.2%-0.4%+2.4%

Close-to-close from the session before the filing could trade. Day 0 is the first session after it.

Growth · Q2 FY27

Revenue YoY+57.5%
Profit YoY+328.3%
Interest cost YoY—
Revenue QoQ+25.6%
Profit QoQ+38.6%
CAGR2Y3Y4Y5Y6Y7Y
Revenue+1.8%-14.8%-9.9%—-1.7%—
Profit-43.3%+16.9%——+45.5%—

Key data

Open332.55
Day range315.10 – 332.55
52-week range87.15 – 426.60
From 52w high-25.7%
RSI (14)38.7
ATR (14)22.19
Volume4.85L
Avg volume (20D)8.02L
Rel volume0.60×
Volatility (1Y)60.2%
Turnover₹15.5Cr
Traded value (NSE)₹15.5Cr
VWAP320.15
SMA 50 / 200367.96 / 233.35
Price band20%

Delivery percentage

Latest · 20 Nov 202649.8%
20-day avg45.7%
1-year avg47.1%
Percentile (own history)35th
Range3.9–100.0%
Sessions3,516

Over the last 20 sessions INDSWFTLAB settled 45.7% of its traded quantity, which is above average for an NSE equity. That is in line with its own one-year average of 47.1%. The latest session ranks higher than 35% of the 3,516 sessions on record for it.

What delivery percentage measuresScan the whole market on delivery

Dividends, deals & holders

Dividend yield0.00%
Dividend, trailing 12M₹0.00
Paid every year for0 yr
Shareholders42.7K · +1.3% QoQ
Net bulk deals, 30D0.00%
Block deals, 30D₹0
Last bulk buy175 days ago

Performance returns

1D1W1M3M6M1Y
Price-3.98%-12.25%-8.19%-4.94%+134.24%+205.59%

Valuation

Market cap₹2,757 Cr
Market cap (NSE)₹2,757 Cr
Free-float cap₹1,573 Cr
P/E (TTM)33.0
P/E (NSE)34.4
EPS (TTM)9.61
P/B1.9
Net margin (TTM)11.1%
Other income / PBT43.2%
ROE6.0%
Debt / equity0.01
Shares outstanding8.70Cr
Listed2 Jul 1997

Ownership

Promoter42.93%
Promoter Δ QoQ0.00 pp
Public57.07%
FII10.78%
DII0.20%
Pledged0.00%

Quarterly results · consolidated

Q3 FY26Q4 FY26Q1 FY27Q2 FY27
Revenue (₹ Cr)150.9169.8191.5240.5
YoY chg+1641.1%+22.8%+25.4%+57.5%
Net profit (₹ Cr)9.515.124.734.2
YoY chg+153741.9%-93.2%+181.3%+328.3%
Net margin6.3%8.9%12.9%14.2%
EPS1.131.762.843.92

Shareholding over time

By quarter

30 Sept 2026 · promoter 42.93% · public 57.07%
30 Sept 2021: promoter 42.00%31 Dec 2021: promoter 42.00%31 Mar 2022: promoter 42.00%30 Jun 2022: promoter 42.00%30 Sept 2022: promoter 42.00%31 Dec 2022: promoter 42.00%31 Mar 2023: promoter 42.00%30 Jun 2023: promoter 42.00%30 Sept 2023: promoter 42.00%31 Dec 2023: promoter 42.00%31 Mar 2024: promoter 42.00%30 Jun 2024: promoter 42.00%30 Aug 2024: promoter 42.00%30 Sept 2024: promoter 42.00%31 Dec 2024: promoter 42.00%18 Mar 2025: promoter 40.94%31 Mar 2025: promoter 40.94%30 Jun 2025: promoter 40.94%2 Jul 2025: promoter 38.57%21 Jul 2025: promoter 36.77%1 Aug 2025: promoter 37.72%25 Aug 2025: promoter 39.50%30 Sept 2025: promoter 39.50%31 Dec 2025: promoter 39.50%24 Feb 2026: promoter 43.06%31 Mar 2026: promoter 42.99%30 Jun 2026: promoter 42.93%17 Sept 2026: promoter 42.93%30 Sept 2026: promoter 42.93%
2021-092026-09
  • Promoter
  • Public and others
Promoter
42.93%
Public
57.07%
Promoter change
0.00 pp
Filed
15 Oct 2026
FII
10.78%
DII
0.20%
Promoter pledged
0.00%

Who the public is

Mutual funds
0.00%

0.00 pp QoQ

Insurance
0.00%

0.00 pp QoQ

FPI
10.78%

-0.12 pp QoQ

Retail ≤ ₹2L
13.56%

+0.17 pp QoQ

HNI > ₹2L
21.84%

+0.03 pp QoQ

NRI
2.33%

+0.01 pp QoQ

Bodies corporate
6.24%

-0.04 pp QoQ

Shareholders
42,667

+1.3% QoQ

Major holders

As of 30 Sept 2026
HolderTypeHolding
ESSIX BIOSCIENCES LIMITEDPromoter · Corporate37.81%
ZEAL GLOBAL OPPORTUNITIES FUNDFPI4.62%
NOVA GLOBAL OPPORTUNITIES FUND PCC - TOUCHSTONEFPI3.32%
PANCHKULA FINVEST PRIVATE LIMITEDCorporate2.48%
ASHOKKUMAR CHANDAKIndividual2.42%
ZAKI ABBAS NASSERIndividual2.00%
PRANAV JONEJAIndividual1.44%
ARK GLOBAL EMERGING COMPANIES, LPFPI1.40%
SHARWAN SINGH GULERIAIndividual1.32%
NAVRATTAN MUNJALPromoter · Individual1.16%

Every promoter-group member, and each public holder above 1%, as filed.

Promoter and public shares of total equity, from the pattern filed each quarter. Institutional, pledge and public-breakdown figures come from the filing's XBRL, which most filings before Sep-2021 lack, so they are absent there rather than zero. Changes are against the previous filing.

52-week highs & lows

Loading…

Each session the stock traded past its previous 52-week high or low, from NSE's daily report; the previous figure is the record it broke. Prices as published, not split-adjusted.

Price-band hits

Loading…

Sessions the stock closed at the limit of its daily price band, from NSE's end-of-day list. A stock pinned at the band could not trade past it that day.

Insider trades

Insiders net, 30d
₹0
Insiders net, 90d
−₹25.1L
Promoters net, 90d
₹0
Insider buyers, 90d
0
Last promoter buy
none on record
Disclosures on record
75
25 open-market of the newest 75
By year
BroadcastPersonSideSharesValuePriceHolding before → afterStakeRegulation
28 Sept 2026PARDEEP VERMAKMPSell6.1K₹25.1L408.791.74L → 1.68L0.19%-0.01 pp7(2)told 28 Sept 2026
12 Sept 2024GAGAN AGGARWALKMPSell30.0K₹42.4L141.411.70L → 1.40L0.24%-0.05 pp7(2)told 10 Sept 2024
30 Jun 2023ATUL KUMAR CHAUBEYEmployeeSell38.5K₹33.2L86.2338.5K → —0.00%7(2)told 30 Jun 2023
19 Jun 2023RAJESH NAGEmployeeSell25.8K₹18.8L72.8125.8K → —0.00%7(2)told 17 Jun 2023
7 Jun 2023SATISH SHARMAEmployeeSell14.8K₹10.7L72.1514.8K → —0.00%7(2)told 6 Jun 2023
5 Jun 2023LOVEKESH MAHAJANEmployeeSell15.0K₹10.8L72.0080.2K → 65.2K0.11%-0.03 pp7(2)told 5 Jun 2023
3 Jun 2023LOVEKESH MAHAJANEmployeeSell21.9K₹15.7L71.411.02L → 80.2K0.13%-0.04 pp7(2)told 2 Jun 2023
1 Dec 2022PRADEEP KUMAR GOELEmployeeSell15.0K₹9.6L64.0020.0K → 5.0K0.01%-0.03 pp7(2)told 1 Dec 2022
30 Nov 2022PRADEEP KUMAR GOELEmployeeSell19.1K₹12.3L64.4939.1K → 20.0K0.03%-0.03 pp7(2)told 30 Nov 2022
22 Sept 2022PRADEEP KUMAR GOELOtherSell27.6K₹16.4L59.5269.3K → 41.7K0.07%-0.05 pp7(2)told 21 Sept 2022
23 Sept 2021ANURAG CHATURVEDIOtherSell10.6K₹7.5L70.3410.6K → —0.00%7(2)told 21 Sept 2021
23 Sept 2021ANURAG CHATURVEDIOtherSell10.0K₹7.5L74.6020.6K → 10.6K0.02%-0.02 pp7(2)told 21 Sept 2021
23 Sept 2021ANURAG CHATURVEDIOtherSell5.0K₹5.0L99.8425.6K → 20.6K0.03%-0.01 pp7(2)told 21 Sept 2021
1 Apr 2021VIJAY KUMAREmployeeSell14.5K₹10.4L72.001.00L → 85.5K0.14%-0.02 pp7(2)told 31 Mar 2021
24 Mar 2021RAJESH NAGEmployeeSell18.0K₹14.2L79.0043.9K → 25.9K0.04%-0.03 pp7(2)told 24 Mar 2021
17 Mar 2021RAJESH NAGEmployeeSell20.0K₹17.0L85.0063.9K → 43.9K0.07%-0.03 pp7(2)told 17 Mar 2021
17 Mar 2021LALIT KUMAR WADHWAEmployeeSell5.0K₹4.3L86.751.53L → 1.48L0.25%-0.01 pp7(2)told 16 Mar 2021
17 Mar 2021SATISH SHARMAEmployeeSell17.1K₹13.6L79.5431.9K → 14.8K0.02%-0.02 pp7(2)told 17 Mar 2021
13 Mar 2021LALIT KUMAR WADHWAEmployeeSell15.0K₹11.8L78.411.68L → 1.53L0.26%-0.03 pp7(2)told 12 Mar 2021
18 Feb 2021VARUN CHHABRAEmployeeSell29.0K₹20.8L71.7636.0K → 7.0K0.01%-0.04 pp7(2)told 17 Feb 2021
2 Jan 2021SANDEEP SINGHEmployeeSell43.1K₹26.9L62.2993.1K → 50.0K0.08%-0.07 pp7(2)told 1 Jan 2021
31 Dec 2020LALIT KUMAR WADHWAEmployeeSell22.0K₹14.2L64.741.90L → 1.68L0.28%-0.04 pp7(2)told 30 Dec 2020
18 Dec 2020AJIT KUMAREmployeeSell19.0K₹11.6L61.1634.8K → 15.8K0.02%-0.02 pp7(2)told 18 Dec 2020
12 Dec 2020PRADEEP KUMAR GOELEmployeeSell20.0K₹12.3L61.501.10L → 90.0K0.15%-0.03 pp7(2)told 10 Dec 2020
4 Dec 2020SARANJAI TYAGIEmployeeSell23.0K₹14.4L62.4423.0K → —0.00%7(2)told 3 Dec 2020

SEBI insider-trading disclosures, equity only. Dated by the day NSE broadcast them; the trade itself is often weeks earlier. The figures count promoters, directors and KMPs buying or selling on the exchange — not ESOPs, gifts, transfers within the promoter group or pledges. Stake is the holding after, as filed; the change beneath it scales that by the share counts before and after. Regulation is the PIT clause cited, and “told” the day the insider informed the company.

How the insider figures are countedPromoters buying in the open market, market-wideEvery stock on this session

Filings

CSV
Loading…

Bulk & block deals · 29 May 2026

CSV
12 of 202 deals
By year
DateDealClientQuantityPriceValue
29 May 2026Buy · bulkHRTI PRIVATE LIMITED6.71L155.10₹10.4Cr
29 May 2026Sell · bulkHRTI PRIVATE LIMITED2.03L153.04₹3.1Cr
17 Apr 2026Sell · bulkHCP INVESTMENTS48.00L134.18₹64.4Cr
17 Apr 2026Sell · bulkF3 ADVISORS PRIVATE LIMITED8.35L133.17₹11.1Cr
17 Apr 2026Buy · bulkNOVA GLOBAL OPPORTUNITIES FUND PCC - TOUCHSTONE8.03L138.07₹11.1Cr
17 Apr 2026Buy · bulkMANSI SHARE AND STOCK BROKING PRIVATE LIMITED7.99L132.66₹10.6Cr
17 Apr 2026Sell · bulkMANSI SHARE AND STOCK BROKING PRIVATE LIMITED6.96L136.17₹9.5Cr
17 Apr 2026Buy · bulkF3 ADVISORS PRIVATE LIMITED7.02L133.25₹9.4Cr
17 Apr 2026Buy · bulkSHARE INDIA SECURITIES LIMITED6.90L134.28₹9.3Cr
17 Apr 2026Sell · bulkSHARE INDIA SECURITIES LIMITED5.82L135.53₹7.9Cr
17 Apr 2026Sell · bulkD3 STOCK VISION LLP4.84L132.81₹6.4Cr
17 Apr 2026Buy · bulkPARTH INFIN BROKERS PVT LTD4.79L132.76₹6.4Cr

A bulk deal is a client trading over 0.5% of the company’s shares in a day; a block deal is one large trade in the separate block window. Quantities and prices are as NSE published them, not split-adjusted.

Every stock on this session →

Takeover-code disclosures

Loading…

Filed under SEBI’s takeover regulations when a holding crosses 5% of the company, and again with every 2% it moves after that. Shares and percentages as filed.

Every stock on this session →

Short selling, lending & margin

Loading…

Shares bought on broker margin funding (MTF) and still held at the day’s end, and the amount brokers have lent against them.

Exchange surveillance

20 Nov 2026
  • Long-term ASM · Stage I · since 12 Aug 2026 — Long-term Additional Surveillance Measure: after a sustained unusual move, trades carry a higher margin and, at later stages, settle trade-for-trade.

Price band: 20% · not in the F&O ban.

From NSE’s daily surveillance, price-band and position-limit files. A stock enters the F&O ban when open interest passes 95% of its market-wide position limit and leaves it below 80%; until then no new positions can be opened. CSV: measures · band changes.

Every stock on this session →

Financials · quarterly statement

₹ crore, as filed
By year
 Q3 FY24Q4 FY24AQ1 FY25Q2 FY25Q3 FY25Q4 FY25AQ1 FY26Q2 FY26Q3 FY26Q4 FY26AQ1 FY27Q2 FY27
Revenue from operations287.5393.333.212.08.7138.2152.7152.6150.9169.8191.5240.5
Other income7.125.311.113.013.84.514.617.927.62.27.77.6
Total income294.6418.644.325.022.5142.7167.3170.5178.4172.0199.1248.1
Total expenses270.9431.843.324.423.6128.1157.0160.2156.2154.9166.3204.1
└ Finance costs21.1(11.5)0.20.40.1(26.8)1.22.00.7(2.4)0.71.3
└ Depreciation13.612.70.20.20.27.46.77.08.88.17.67.8
Profit before tax23.8373.31.00.6(1.1)230.510.410.316.412.032.643.4
Tax expense4.2134.5(0.0)0.2(1.1)8.21.72.34.0(3.1)8.09.2
Net profit19.4238.90.90.40.0222.38.88.09.515.124.734.2
EPS3.2940.420.160.070.0032.961.281.001.171.812.843.94
Net margin6.75%60.73%2.82%3.46%0.07%160.79%5.74%5.23%6.32%8.90%12.89%14.23%
PBT margin8.27%94.92%2.95%4.88%-12.48%166.72%6.78%6.78%10.87%7.04%17.01%18.04%
Tax rate17.86%36.02%-2.94%31.61%—3.55%16.47%22.24%24.40%-26.34%24.54%21.27%

A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. The balance sheet and cash flow arrive only with the half-year and annual filings, and are in their own section below. Latest filed 29 Oct 2026.

Balance sheet & cash flow · half-yearly

₹ crore, as filed
By year

Balance sheet

 FY23H1 FY24FY24H1 FY25FY25H1 FY26FY26H1 FY27
Total assets1,824.11,799.31,165.11,188.01,438.31,544.41,673.31,771.2
Current assets1,164.51,164.2661.1586.8865.3843.8976.81,022.7
└ Cash & equivalents18.213.2431.9438.5428.0399.9429.8340.4
└ Other bank balances0.00.00.00.00.00.00.00.0
└ Current investments0.00.00.00.039.419.411.945.0
└ Trade receivables505.3513.6169.157.5164.5175.3198.5245.1
└ Inventories438.6441.310.59.3114.2108.6147.9170.1
Total equity681.9730.3931.41,011.51,173.01,307.41,384.01,474.3
└ Attributable to owners681.9730.3931.51,011.51,173.01,307.51,384.01,474.4
└ Non-controlling interest0.0—(0.0)(0.0)(0.0)(0.1)(0.1)(0.1)
└ Share capital59.859.859.159.168.781.686.887.0
Borrowings861.5801.116.616.440.621.817.919.6
└ Current108.973.25.55.514.913.15.64.4
└ Non-current752.6727.911.210.925.78.812.315.2
Trade payables204.0184.294.041.2110.2118.7145.9135.5
Current liabilities371.1321.7221.3164.4220.6209.6254.7262.1
Total liabilities1,142.11,069.0233.7176.5265.4237.0289.4296.9
Net debt843.3787.9(415.3)(422.1)(426.8)(397.5)(423.8)(365.8)
Debt / equity1.261.100.020.020.030.020.010.01
Current ratio3.143.622.993.573.924.033.833.90

Cash flow, year to date

 FY23H1 FY24FY24H1 FY25FY25H1 FY26FY26H1 FY27
Operating cash flow194.698.8(180.9)(23.2)(25.5)(20.3)(63.2)(34.7)
└ Capex(12.8)(9.7)(44.5)(0.1)(64.4)(27.0)(87.7)(67.0)
Free cash flow181.889.1(225.4)(23.3)(89.9)(47.3)(150.9)(101.7)
Investing cash flow(13.4)(6.5)(104.3)(48.6)(109.6)(104.0)(72.7)(86.0)
Financing cash flow(185.7)(97.8)698.978.369.296.1141.834.1
└ Dividends paid0.00.00.00.00.00.00.00.0
└ Buybacks0.00.00.00.00.00.00.00.0
Net change in cash(4.4)(5.4)413.36.3(66.5)(28.1)5.9(89.5)

From the half-year and annual results filings: the balance sheet from September 2022, the cash flow from September 2020. Those are when NSE’s XBRL began to carry each statement; earlier filings have it only in the attached PDF. Cash flow columns are year to date, so an H1 column covers April to September and an FY column the full year. Outflows are in parentheses. Net debt is borrowings less cash, bank balances and current investments; for banks, NBFCs and insurers it, debt to equity and the current ratio are left blank because their statements are not built that way.

Announcements & board meetings

Loading…

As the company filed them with NSE, newest first. Board meetings are dated by the meeting, which is usually a week or more after the intimation.

Every stock on this session →

INDSWFTLAB at a glance

  • INDSWFTLAB closed at ₹317.05 on 20 Nov 2026, -3.98% on the day, +205.6% over one year, 25.7% below its 52-week high of ₹426.6.
  • Delivery was 49.8% of traded quantity on 20 Nov 2026, the 35th percentile of its own 3,516 sessions with a reading (20-session average 45.7%, 1-year average 47.1%).
  • Market capitalisation is ₹2,757 crore at a trailing P/E of 33.0 (trailing EPS ₹9.61).
  • Q2 FY27 results (consolidated, filed 29 Oct 2026): revenue ₹240 crore (+57.5% year on year), net profit ₹34 crore (+328.3%); the price moved -10.2% on the first session after.
  • Promoters held 42.93% at 30 Sept 2026, unchanged on the previous filing.
  • Q3 FY27 results are expected between 31 Jan 2027 and 15 Feb 2027, going by past filing dates — an estimate, not an announcement.

About

Macro sectorHealthcare
Basic industryPharmaceuticals
ISININE915B01019
SeriesEQ
Listed2 Jul 1997
NSE market cap · 17 Nov 2026₹2,886 Cr
Free-float market cap (NSE)₹1,623 Cr
Shares outstanding (NSE)8.70Cr
History from16 Jul 1997
Sessions7,158
Turnover rank#592

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 20 Nov 2026.